Luís Morano

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

María Luisa Manzano, Rosa M. Morillas, Montserrat Garcı́a-Retortillo et al. · PLoS ONE · 2017 · 96 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron et al. · The Lancet HIV · 2020 · 70 citations · Full text

Public Health, Immunology, Infectious Diseases +8

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

Juan Macı́as, Luís Morano, Francisco Téllez et al. · Journal of Hepatology · 2019 · 69 citations

Medicine, Pharmacology, Pharmacotherapy +11

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B

Jinlin Hou, Wenhong Zhang, Qing Xie et al. · New England Journal of Medicine · 2024 · 69 citations · Full text

Pharmacy, Immunology, Pharmacology +15

1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

Peter Ferenci, Tarik Asselah, Graham R. Foster et al. · Journal of Hepatology · 2013 · 54 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15